Eruptive Nevi Mimicking Wart-Like Lesions under Selective BRAF Inhibition in a 37-Year-Old Female Melanoma Patient

• Main Authors: Laurenz Schmitt (Author), Tamara Schumann (Author), Oliver Inhoff (Author), Christoph Löser (Author), Martin Rebel (Author), Edgar Dippel (Author)
• Format: Book
• Published: Karger Publishers, 2013-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The BRAF inhibitor vemurafenib is state of the art in therapy of patients with malignant melanoma in non-resectable stage III or stage IV and evidence of oncogenetic BRAF mutation. Multiple cutaneous side effects like rash and keratoacanthoma-like lesions have been described so far. Case...